12:00 AM
Dec 24, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Sitavig regulatory update

BioAlliance said 8 European countries recommended approval of Sitavig acyclovir Lauriad to treat recurrent labial herpes. Sweden acted as the reference member state under the decentralized procedure. BioAlliance said...

Read the full 123 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >